Cargando…
Synergistic inhibitory effects of the oxyresveratrol and dacarbazine combination against melanoma cells
Various therapies have been developed to target malignant melanoma, which is associated with a high mortality rate worldwide. Although dacarbazine (DTIC) is employed for treating melanoma, it is associated with several side effects. Hence, patients with melanoma are co-treated with additional drugs...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299023/ https://www.ncbi.nlm.nih.gov/pubmed/34386089 http://dx.doi.org/10.3892/ol.2021.12928 |